Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.55 |
---|---|
High | 1.63 |
Low | 1.30 |
Bid | 1.37 |
Offer | 1.59 |
Previous close | 1.58 |
Average volume | 65.61k |
---|---|
Shares outstanding | 21.98m |
Free float | 10.24m |
P/E (TTM) | -- |
Market cap | 34.74m USD |
EPS (TTM) | -8.19 USD |
Data delayed at least 15 minutes, as of Oct 31 2024 20:00 BST.
More ▼
- Celularity Presents Data of The Effect of Its T-Cell Platform on Multiple Hematological And Solid Tumors at the American Society of Clinical Oncology (ASCO) Annual Meeting
- Celularity Inc. to Host Investor and Analyst Research & Development Day
- Celularity Announces Net Sales Trending Ahead of Expectations for First Quarter 2024; Implements Planned 2024 SG&A Reductions and Manufacturing Ramp for Advanced Biomaterial Products